The Benderson family of Sarasota, Florida, donated $5 million to the Dana-Farber Cancer Institute in Boston, MA, representing the largest philanthropic gift addressing triple-negative breast cancer research (TNBC) and care in the history of the research center. Actually the second major gift from the family to Dana-Farber in support of TNBC, the Benderson Family Program for Triple-Negative Breast Cancer is established.
The Challenge & Opportunity
Triple-negative breast cancer is one of the most challenging forms of breast cancer to treat. Chemotherapy remains the backbone of treatment, but with the ongoing clinical trials at Dana-Farber, new therapies such as immunotherapies, antibody drug conjugates, and PARP inhibitors are now under investigation.
TNBC represents challenges as other cancers for example are hormone receptor or HER2 positive, this condition has no targeted treatments hence patents must rely primarily on surgery, chemotherapy and radiation, which are less effective than targeted treatments and often bring significant side effects.
Now thanks to the Benderson gift, Dana-Farber will expand a novel comprehensive TNBC research reg...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).